Advertisement

Julian Schink, MD, Named Chief Medical Officer of CTCA


Advertisement
Get Permission

Julian Schink, MD

Julian Schink, MD

JULIAN SCHINK, MD, has been appointed Chief Medical Officer of Cancer Treatment Centers of America (CTCA). As Chief Medical Officer for the comprehensive cancer care network, Dr. Schink will provide leadership and direction for its enterprise-wide clinical programs and will serve as a liaison between physicians and administrative leaders across the enterprise.

Dr. Schink joined the CTCA in May 2017 as Chief of Gynecologic Oncology and serves in a regional clinical leadership capacity at CTCA Chicago, where he also cares for patients at both the CTCA Comprehensive Care and Research Center in Zion, Illinois, and the Downtown Chicago Outpatient Cancer Center.

“I am excited to take on this new challenge,” Dr. Schink said. “I’m thrilled to work with my talented colleagues across the enterprise and am laser-focused on the opportunities we have to expand access to innovative treatment options and compassionate care for patients across the United States and internationally.”

Dr. Schink has held numerous academic positions, including Vice Chair of Obstetrics and Gynecology and Professor at the University of Wisconsin Medical School as well as an Endowed Professorship at Northwestern University Feinberg School of Medicine as the John I Brewer Professor of Gynecology and Cancer Research. He has been a member of and held leadership positions at several medical organizations, including the American College of Obstetricians and Gynecologists, the Society of Gynecologic Oncology, and the Gynecologic Cancer Foundation. Dr. Schink has also received several awards for his work, including listings in America’s Top Doctors, The Best Doctors in America, and Chicago Super Doctors.

Dr. Schink received his medical degree from The University of Texas Health Science Center at San Antonio. He completed his residency training in obstetrics and gynecology at Northwestern University Medical School, followed by a fellowship in gynecologic oncology at the University of California, Los Angeles Medical School.


Advertisement

Advertisement



Advertisement